Status
Conditions
Treatments
About
Subjects will include patients diagnosed with breast cancer or hematological cancer who are planned for chemotherapy treatment with anthracycline or trastuzumab; and who have one or more risk factors for cardiovascular disease. Subjects will received an extra echocardiogram to determine if heart problems can be detected earlier.
Full description
Sex
Ages
Volunteers
Inclusion criteria
Males and females 18 years and above
Willing and able to provide consent
Able to read
Patients diagnosed with breast cancer or hematological cancer who are planned for chemotherapy treatment with anthracycline or trastuzumab.
Patients at increased risk of cardiotoxicity with one or more risk factors for heart disease:
Exclusion criteria
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal